MXPA04004807A - Composiciones y metodos para inhibir la resorcion osea. - Google Patents

Composiciones y metodos para inhibir la resorcion osea.

Info

Publication number
MXPA04004807A
MXPA04004807A MXPA04004807A MXPA04004807A MXPA04004807A MX PA04004807 A MXPA04004807 A MX PA04004807A MX PA04004807 A MXPA04004807 A MX PA04004807A MX PA04004807 A MXPA04004807 A MX PA04004807A MX PA04004807 A MXPA04004807 A MX PA04004807A
Authority
MX
Mexico
Prior art keywords
compositions
methods
vitamin
bone resorption
disclosed
Prior art date
Application number
MXPA04004807A
Other languages
English (en)
Inventor
John D Kirsch
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to MXPA04004807A priority Critical patent/MXPA04004807A/es
Publication of MXPA04004807A publication Critical patent/MXPA04004807A/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen composiciones y metodos para prevenir, inhibir, reducir o tratar condiciones y enfermedades asociadas con resorcion osea anormal en mamiferos incluyendo, por ejemplo, osteoporosis; las modalidades de las composiciones de la invencion, comprenden una cantidad farmaceuticamente efectiva de alendronato y vitamina D3 adecuada para dosificacion una vez por semana; las composiciones y los metodos de la invencion proveen nutricion de vitamina D durante el tratamiento con bisfosfonato, para facilitar la formacion y mineralizacion normal de hueso, mientras se reduce al minimo la ocurrencia de las complicaciones asociadas con insuficiencia de vitamina D, o el potencial para las mismas, tales como hipocalcemia y osteomalacia; se describen tambien metodos para fabricar composiciones de la presente invencion, para medir la estabilidad y la degradacion de esas composiciones, y para medir los niveles de vitamina D en plasma sanguineo.
MXPA04004807A 2004-05-19 2004-05-19 Composiciones y metodos para inhibir la resorcion osea. MXPA04004807A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MXPA04004807A MXPA04004807A (es) 2004-05-19 2004-05-19 Composiciones y metodos para inhibir la resorcion osea.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA04004807A MXPA04004807A (es) 2004-05-19 2004-05-19 Composiciones y metodos para inhibir la resorcion osea.

Publications (1)

Publication Number Publication Date
MXPA04004807A true MXPA04004807A (es) 2005-11-24

Family

ID=36273487

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004807A MXPA04004807A (es) 2004-05-19 2004-05-19 Composiciones y metodos para inhibir la resorcion osea.

Country Status (1)

Country Link
MX (1) MXPA04004807A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014088385A1 (es) 2012-12-03 2014-06-12 Landsteiner Scientific S.A. De C.V. Composición farmacéutica estable para el tratamiento de osteoporosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014088385A1 (es) 2012-12-03 2014-06-12 Landsteiner Scientific S.A. De C.V. Composición farmacéutica estable para el tratamiento de osteoporosis

Similar Documents

Publication Publication Date Title
BRPI0418756A (pt) composições e métodos para inibir a reabsorção óssea
MX2010002971A (es) Metodo para inhibir la reabsorcion del hueso.
MY146809A (en) Treatment and prevention of osteoporosis
MX2010002410A (es) Metodo para proveer los beneficios de energia, alivio del estres y mejora del estado de animo, que comprende administrar una composicion que comprende colecalciferol y un extracto de te.
TWI289451B (en) Use of a bisphosphonate for the manufacture of a medicament for the treatment of conditions of abnormally increased bone turnover
WO2005051323A3 (en) Vitamin d analogs for obesity prevention and treatment
HK1065941A1 (en) Use of a nicotinic acid alkyl ester containing an alkyl chain from 8 to 22 carbon atoms for the preparation of a medicament for increasing leptin levels in a subject
LT2198880T (lt) Kompozicijos, turinčios lipazės, proteazės ir amilazės, skirtos kasos nepakankamumo gydymui
NZ545804A (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-or-vitamin D derivatives and a bisphosphonate
ATE425742T1 (de) Dexpanthenol-, calciumionen- und phosphatfreie pharmazeutische zusammensetzung sowie verwendung von calcium-chelatbildner und ophthalmologisch vertraglichem viskositatsregler
BR112015013539A2 (pt) composições de formação de cimento, cimentos monetita, implantes e métodos para a correção de defeitos de ossos
TW200716146A (en) Method for treating or preventing systemic inflammation in formula-fed infants
AU2009246603A8 (en) Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction
WO2006071456A3 (en) Inhibition of hsp27 phosphorylation for treatment of blistering disorders
NZ598171A (en) Methods and compositions for treating thyroid-related medical conditions with reduced folates
SG10201406846XA (en) Bisphosphonate compounds for treating bone metabolism disorders
TW200719903A (en) Compositions for the treatment of neoplasms
NO20083901L (no) Fiksert-dose-assosiasjon av fytat og sink
MXPA04004807A (es) Composiciones y metodos para inhibir la resorcion osea.
WO2010033981A3 (en) 5-azaindole bisphosphonates
WO2010033980A3 (en) 4-azaindole bisphosphonates
MX2022005448A (es) Método de tratamiento de queratodermia palmoplantar.
WO2007026071A8 (fr) Utilisation de dha sous forme de phospholipides pour la preparation d'une composition destinee au traitement de l'insuffisance respiratoire.
MY148565A (en) Agent for therapy and/or improvement of disseminated intravascular coagulation
EP1809599B8 (en) Vitamin d3 analogues for the prevention and treatment of bone disorders